More than 300 Mount Sinai Health System physicians, nurses, and staff laced up their sneakers to participate in the recent American Heart Association’s (AHA) three-mile Wall Street Run and Heart Walk. Team members raised $52,000 to help the AHA advance its cardiovascular research. They wore pink and black T-shirts designed by Jonathan P. Kyriacou, a Director of Hospital Operations, who won the “Best T-shirt” contest initiated by Lisa Allen, Administrative Director, Cardiology, Mount Sinai Beth Israel.
More than 50 Mount Sinai Health System employees and their families and friends, led by Icahn School of Medicine at Mount Sinai students Kyle Riley and Dudley Charles as parade co-captains, marched together during the 46th Annual New York City Pride Parade on Sunday, June 28. The Mount Sinai Health System walkers entered Fifth Avenue early in the parade and marched approximately three miles downtown to Washington Square and Christopher Street. A Mount Sinai St. Luke’s ambulance decorated with rainbow flags followed the group. Staff and volunteers from Mount Sinai’s Institute for Advanced Medicine also hosted booths at PrideFest, a Pride Day street festival in the West Village, distributing information about the many health services the Health System provides to the LGBT community.
Singer and musician Johannes Schwaiger—who lost his voice after radiation treatment for throat and neck cancer but regained it following treatment at Mount Sinai Beth Israel—entertained more than 200 guests at Mount Sinai’s annual National Cancer Survivors Day® luncheon, held recently at Mount Sinai Beth Israel Phillips Ambulatory Care Center. Among the attendees were cancer survivors, their families and friends, and Mount Sinai faculty and staff. Charles L. Shapiro, MD, Professor of Medicine, Co-Director of the Dubin Breast Center at The Mount Sinai Hospital, Director of Translational Breast Cancer Research, and Director of Cancer Survivorship, Tisch Cancer Institute, delivered the keynote address. “More cancer survivors will experience cures, mainly due to screening, early detection, and improved treatments and supportive care,” Dr. Shapiro says. “Sometimes treatment causes long-term side effects that can affect survivors’ quality of life, so we need to prevent or treat them effectively.”
In 2011, Mount Sinai embarked on a strategy—across many digital and traditional channels—to ensure a consistent message of growth, strength, and excellence.
It began with the first steps to develop a new logo, and with it, a mission, vision, and values to propel the institution forward as health care in the United States took a revolutionary turn. Read more
A new chapter is unfolding at the Mount Sinai Health System, one that defines Mount Sinai’s leadership in providing seamless patient care—for you, for life—throughout New York City. It also showcases Mount Sinai’s significant contributions to research and medical education, and highlights innovative collaborations around the world that advance health care. For the first time since the Health System was formed in 2013, this story is being shared with the public in an advertising campaign that was launched in the Sunday, July 19, issue of The New York Times Magazine. Read more
A unique method of increasing the number of cord blood stem cells used to treat patients with blood cancers and blood disorders, such as sickle cell anemia, is being readied for clinical trials at the Icahn School of Medicine at Mount Sinai, with an $8.8 million grant from the New York State Stem Cell Science Program (NYSTEM).
The stem cells—also known as hematopoietic stem cells—are derived from the vein of the umbilical cord and help renew and replenish blood cells. They represent the only potential therapy for blood cancer patients who do not respond to chemotherapy. The new method is necessary to compensate for the limited number of stem cells that are typically found in blood cord collections and the fact that using stem cells from two or more blood cord collections is generally not a viable option because the blood cells are not identical. Read more
Sean P. Pinney, MD, was recently named the first Director of Heart Failure and Transplantation for the Mount Sinai Health System. He will also continue to serve as Director of Advanced Heart Failure and Transplantation at The Mount Sinai Hospital and Associate Professor of Medicine (Cardiology) at Icahn School of Medicine at Mount Sinai, where he has led a number of clinical trials in heart failure, cardiac transplantation, and mechanical circulatory support. Read more
Mount Sinai scientists and clinicians are making notable advances in the study and treatment of heart failure, a common condition that occurs when the heart becomes too weak to pump and circulate enough blood through the body. Diseases that damage the heart—such as coronary artery disease, high blood pressure, and diabetes—can lead to heart failure, which develops over time as the heart’s pumping action grows weaker. It impacts an estimated 5 million adults and children in this country. Read more
The Mount Sinai Transplant Living Center, which provides convenient and affordable overnight accommodations to patients and their families receiving care at the Recanati/Miller Transplantation Institute (RMTI), has undergone a full renovation, featuring new kitchens, bathrooms, and furniture.
The renovation was a generous gift from benefactors Ken and Meryl Sherman who were looking to give back to RMTI on the fourteenth anniversary of Mrs. Sherman’s successful kidney transplant, for which Mr. Sherman was the donor. Read more
Before a capacity audience in Stern Auditorium that included faculty, staff, students, and the public, Atul Gawande, MD, MPH, noted surgeon, writer, and public health researcher, recently presented a professional overview—yet highly personalized account—of modern medicine’s impact on how we age, and die, in the twenty-first century. His speech, titled “Being Mortal,” based on his book, Being Mortal: Medicine and What Matters in the End, was delivered as the 2015 Annual Douglas West Memorial Lecture, an event sponsored by Mount Sinai’s Lilian and Benjamin Hertzberg Palliative Care Institute. Read more